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Abstract 
Emerging evidence suggests that imagery-based techniques may enhance the effectiveness 
of traditional verbal-linguistic cognitive interventions for emotional disorders. This study 
extends an earlier pilot study by reporting outcomes from a naturalistic trial of an imagery-
enhanced cognitive behavioural group therapy (IE-CBGT, n = 53) protocol for social 
anxiety disorder (SAD), and comparing outcomes to historical controls who completed a 
predominantly verbally-based group protocol (n = 129). Patients were consecutive referrals 
from health professionals to a community clinic specialising in anxiety and mood disorders. 
Both treatments involved 12, two-hour group sessions plus a one-month follow-up. Analyses 
evaluated treatment adherence, predictors of dropout, treatment effect sizes, reliable and 
clinically significant change, and whether self-reported tendencies to use imagery in 
everyday life and imagery ability predicted symptom change. IE-CBGT patients were 
substantially more likely to complete treatment than controls (91% vs. 65%).  Effect sizes 
were very large for both treatments, but were significantly larger for IE-CBGT. A higher 
proportion of the IE-CBGT patients achieved reliable change, and better imagery ability was 
associated with larger symptom change. Outcomes compared very favourably to published 
group and individual treatments for SAD, suggesting that IE-CBGT may be a particularly 
effective and efficient mode of treatment delivery. 
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Social anxiety disorder (SAD) is characterised by significant and persistent anxiety 
when exposed to possible scrutiny by others (American Psychiatric Association, APA, 
2013). SAD is one of the most common anxiety disorders, has an early age of onset (median 
12 years), and can be highly debilitating (Andrews, Henderson, & Hall, 2001; McEvoy, 
Grove, & Slade, 2011). Cognitive behavioural therapy (CBT) is highly efficacious within 
research settings (Clark et al., 2003, 2006; Rapee, Gaston, & Abbott, 2009) and effective 
within community clinics (McEvoy, Nathan, Rapee, & Campbell, 2012). However, a 
significant minority of patients remain symptomatic after CBT (McEvoy et al., 2012), so 
further treatment innovations are required. A recent pilot of an imagery-enhanced group 
CBT protocol (IE-CBGT) found high attendance rates and very large effect sizes (McEvoy 
& Saulsman, 2014). The aims of this study were to extend these pilot data by including a 
larger clinical sample, examining weekly trajectories of change, and examining whether 
general imagery use and imagery ability moderate outcomes from IE-CBGT. 
Cognitive theories of emotion (Holmes & Mathews, 2010) and SAD in particular 
(Heimberg, Brozovich, & Rapee, 2014; Ng, Abbott, & Hunt, 2014) suggest that negative 
imagery contributes to the maintenance of emotional disorders. Imagery has been defined as 
multisensory-perceptual representations that may have visual, somatic, auditory, olfactory, 
and/or gustatory elements, and which have particularly strong links to both positive and 
negative emotions (Holmes & Mathews, 2010). Rapee and Heimberg’s (1997) cognitive 
behavioural model suggests that individuals with SAD construct a mental representation of 
the self as seen by others (i.e., the observer perspective), which is guided by a “pre-existing 
image, stored in long-term memory and based on feedback from others, actual images of the 
self (e.g., from mirrors, photographs, etc.), and prior experiences in a given situation. (p. 
744).” An individual’s mental representation of the self is also guided by preferential 
attention on both internal experiences (e.g., physical sensations of blushing) and perceived 
external indicators of evaluation (e.g., others’ non-verbal and verbal behaviour). The model 
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argues that individuals with SAD attempt to formulate the audience’s performance standard 
and then determine whether or not this standard is being met, with any discrepancy being 
used to guide the perceived likelihood and costs of evaluation. The anticipation of 
evaluation then results in a range of physiological, cognitive, and behavioural effects that 
reinforce the individual’s negative mental representation of the self (Heimberg et al., 2014). 
Rapee and Heimberg (1997) argue that the process is the same whether the situation is being 
experienced, anticipated or reflected on. Therefore, images about the self and the 
consequences of evaluation can be present before, during, and after social situations. 
Research has shown that negative imagery is common in high socially anxious 
individuals (Moscovitch, Garvric, Merrifield, Bielak, & Moscovitch, 2011), ubiquitous in 
individuals with SAD (Hackmann, Clark, & McManus, 2000), and features in both 
anticipatory and post-event processing in relation to social stressors (Chiupka, Moscovitch, 
& Bielak, 2012). Importantly, these negative social images reflect the individual’s feared 
outcomes rather than being reality based, and they serve to reinforce negative self-appraisals 
and expectations of negative evaluation from others (Hackmann et al., 2000). Experimental 
studies have found that negative imagery exacerbates anxiety, increases the use of avoidant 
behaviours, increases self-focused attention, results in more negative self-appraisals, and 
interferes with social performance (Hirsch, Clark, Mathews, & Williams, 2003; Hirsch, 
Meynen, & Clark, 2004). These findings suggest that negative imagery is an important 
treatment target for SAD. 
There is also evidence that imagery is a more potent facilitator of cognitive and 
affective change more generally compared to verbal-linguistic activity (Holmes, Lang, & 
Shah, 2009; Holmes & Mathews, 2010). Cognitive interventions within the imagery mode 
may therefore potentiate greater affective shifts in treatment compared to verbal techniques. 
McEvoy and Saulsman’s (2014) pilot study (N = 19) found an imagery-enhanced cognitive 
behavioural group therapy protocol (IE-CBGT) for SAD to be associated with high retention 
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(95%), large effect sizes, and a high proportion of patients achieving reliable improvement. 
The main components in the IE-CBGT protocol were based on those in existing efficacious 
and effective group (Rapee et al., 2009) and individual (Clark et al., 2003) treatments, with 
adaptations to ensure each component was delivered in imagery mode. For example, 
imagery was used prior to cognitive restructuring and behavioural experiments to elicit 
specific beliefs, and afterwards to envisage more realistic conclusions. Metaphorical 
(‘coping’) imagery was developed to assist patients with tolerating anxiety during 
behavioural experiments, and positive imagery was used to develop and road-test new core 
beliefs. Video-feedback was used to modify negative self-images (Harvey, Clark, Ehlers, & 
Rapee, 2000), and past imagery rescripting was used to modify negative core beliefs. 
Past imagery rescripting involves revisiting and modifying recurrent memories, 
associated images, and meanings of past traumas within imagery to alter the encapsulated 
meanings of the original event. Several small clinical trials with SAD patients have found 
that imagery rescripting alone is associated with significant improvements in negative social 
beliefs, the vividness and distress of negative images and early memories, fear of negative 
evaluation, and social anxiety symptoms (e.g., Nilsson, Lundh, & Viborg, 2012; Wild & 
Clark, 2011). To our knowledge, other than the pilot study (McEvoy & Saulsman, 2014), 
past imagery rescripting has not previously been evaluated within a group format. 
Identifying treatment moderators can aid clinical decision-making. It is plausible that 
individuals who naturally tend to operate within an imagery mode in their day-to-day life, 
and who have a greater capacity to elicit vivid imagery, would benefit more from an 
imagery-enhanced treatment. However, a consistent relationship between imagery ability 
and treatment outcomes has not been reported in the literature. Hunt and Fenton (2007) 
found that whilst imagery ability was associated with avoidance during an imagery 
induction procedure, it was unrelated to the efficacy of imagery rescripting for snake 
phobias. The authors note that their measure of imagery ability was suboptimal in terms of 
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non-standard administration and only marginally acceptable internal consistency. In a small 
sample with SAD (N = 23), Lee and Kwon (2013) also failed to find a significant 
association between mental imagery ability and outcomes from imagery rescripting. 
Although poor imagery ability may not necessarily be an impediment to benefiting from 
imagery-based techniques, it is plausible that a comprehensive treatment protocol 
emphasising imagery within each component would be more beneficial for individuals who 
are able to evoke more vivid images. 
The first aim of this naturalistic benchmarking study was to evaluate an IE-CBGT 
protocol for SAD. The current study extends an earlier pilot (McEvoy & Saulsman, 2014) 
by including larger IE-CBGT (N = 53, henceforth referred to as the ‘imagery-enhanced’) 
and historical control (N = 129) samples, and by more comprehensively assessing treatment 
completion and symptom change. Imagery-enhanced outcomes were compared to historical 
controls who attended a predominantly verbally-based CBGT protocol in three ways: (a) the 
proportion of patients completing treatment and mean number of sessions attended, (b) 
trajectories of weekly change and effect sizes, and (c) the proportion of patients achieving 
reliable and clinically significant change. It was hypothesised that the imagery-enhanced 
group would demonstrate higher attendance rates, more rapid change, larger effect sizes, and 
higher rates of reliable and clinically significant change, compared to the historical controls.   
The second aim was to examine whether (a) self-reported tendencies to operate 
within an imagery mode and (b) imagery ability were associated with outcomes in the 
imagery-enhanced group. It was hypothesised that individuals with a stronger natural 
tendency to operate within the visual mode and with greater ability to evoke vivid images 
would benefit more from imagery-enhanced treatment. 
Method 
Participants 
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Inclusion criteria were (a) a Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV; APA, 1994) SAD diagnosis, (b) no current suicidal intent, (c) no psychotic 
illness, and (d) a level of substance use judged by the assessing clinician as unlikely to 
significantly interfere with engagement in treatment. The Mini International 
Neuropsychiatric Interview (MINI PLUS 5.0; Sheehan et al., 2001) was administered by 
masters- or doctorate-level clinical psychologists to establish Axis I disorders. The MINI has 
good validity and converges with other structured interviews (e.g., Sheehan et al., 1997). A 
maximum of three diagnoses were coded in the database. Patients and assessing clinicians 
made a collaborative decision for the patient to attend the social anxiety program if SAD 
was the most debilitating problem. Written informed consent was provided from all patients 
for de-identified data to be used for evaluation purposes and approval for this study was 
received from the health service’s Human Research Ethics Committee (QI 2014_05). 
Imagery-Enhanced Group. Participants comprised 53 consecutive referrals by 
health professionals (general medical practitioners, psychiatrists, psychologists) in 2013 and 
2014 with a diagnosis of SAD to a specialist community mental health clinic. Demographic 
and clinical characteristics of the sample are presented in Table 1. Most (74%) of the 
patients had at least one comorbid disorder, and 34% had at least two additional disorders. 
The most common comorbid disorders were major depression (n = 22), generalised anxiety 
disorder (n = 16), and dysthymia (n = 5). More than half the patients were unemployed and 
most were not in a relationship. About one-fifth of the sample had a past history of self-
harm, suicide attempts, and psychiatric hospitalization, respectively. Most patients were 
born in Australia or New Zealand (n=41), with the remainder from Europe/United Kingdom 
(n = 6), Asia (n = 5), North America (n = 1). 
Historical Control Group. Historical controls comprised of 129 participants 
referred to the same community clinic from September 2007 to September 2012. The 
demographic and clinical characteristics of historical control sample were similar to those of 
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the imagery-enhanced group (see Table 1). The most common comorbid disorders were 
major depression (n = 63), generalised anxiety disorder (n = 38), and dysthymia (n = 18). 
Most participants were born in Australia or New Zealand (n=101), with the remainder from 
Europe/United Kingdom (n=14), Asia (n = 6), South America (n = 1), and Other (n = 7). 
Outcome Measures 
Social Phobia Scale (SPS) & Social Interaction Anxiety Scale (SIAS).  The SPS 
and SIAS (Mattick & Clarke, 1998) are 20-item measures of performance and interaction 
anxiety, respectively. The SPS describes situations in which the person is the focus of 
attention and observed by others, such as eating, drinking, and writing. The SIAS contains 
items reflecting cognitive, affective, and behavioural reactions to interaction situations, such 
as nervousness when speaking to authority or mixing with people. The 5-point response 
scale for both scales is Not at all, Slightly, Moderately, Very, or Extremely characteristic of 
me. These scales have demonstrated high 12-week test-retest reliabilities (SIAS r = .92; SPS 
r = .93, Mattick & Clarke, 1998) and sensitivity to change (Cox, Ross, Swinson, & 
Direnfeld, 1998). Internal consistencies were high for the SIAS (αs  > .81) and the SPS (αs  > 
.92) across all time points in the current sample. 
Brief Fear of Negative Evaluation-Straightforwardly Worded (BFNE-S, 
Rodebaugh et al., 2004). The BFNE-S is an 8-item self-report measure of fear of negative 
evaluation that excludes four negatively worded (i.e., reverse-scored) items from the original 
12-item version (Leary, 1983). The eight straight-forwardly worded items (BFNE-S) have 
demonstrated superior psychometric properties and less bias associated with education level 
than the 12-item version, and has excellent internal consistency, factorial validity and 
construct validity in analogue and clinical samples (Rodebaugh et al., 2004; Weeks et al., 
2005). Respondents indicate how characteristic each statement is of them on a 5-point 
response scale, not at all, slightly, moderately, very, or extremely characteristic of me. 
Excellent internal consistency was demonstrated in the current sample (αs > .84). 
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Depression, Anxiety and Stress Scale (DASS-21). The DASS-21 (Lovibond & 
Lovibond, 1995) is a shorter version of the original 42-item version. The DASS-21 has 
excellent psychometric properties in psychiatric settings (Page, Hooke, & Morrison, 2007), 
including a robust factor structure, internal consistency, and sensitivity to change during 
treatment. Respondents indicate the degree to which each item applies to them: 0 = did not 
apply to me at all, 1 = applied to me to some degree or some of the time, 2 = applied to me 
to a considerable degree or a good part of the time, and 4 = applied to me very much or 
most of the time. Internal consistency was very high in the current sample (αs > .91).  
Spontaneous Use of Imagery Questionnaire (SUIS). The SUIS (Reisberg, Pearson, 
& Kosslyn, 2003) is a 12-item measure of habitual imagery use. An example item is “When 
going to a new place, I prefer directions that include detailed descriptions of landmarks 
(such as the size, shape, and colour of a petrol station) in addition to their names.” 
Respondents indicate the degree to which each item is appropriate for them using a 5-point 
scale: 5 = completely appropriate, 3 = appropriate about half of the time, and 1 = never 
appropriate. Internal consistency was very high in the current sample (α = .84). 
Vividness of Visual Imagery Questionnaire (VVIQ). Consistent with previous 
literature (e.g., Reisberg et al., 2003), we used an abbreviated 4-item version of the 16-item 
VVIQ (Marks, 1977). The VVIQ has demonstrated acceptable split-half and internal 
consistency (McKelvie, 1986) and is unifactorial (Richardson, 1999). Instructions were, 
“For the visualisation task below, consider carefully the picture that comes before your 
mind’s eye.” The VVIQ asks respondents to visualise a rising sun and then rate how clearly 
and vividly they imagined: (a) the sun is rising above the horizon into a hazy sky, (b) the sky 
clears and surrounds the sun with blueness, (c) clouds, a storm blows up, with flashes of 
lightning, and (d) a rainbow appears. The items are rated on a 5-point scale: 1 = Perfectly 
clear and as vivid as normal vision, 2 = clear and reasonably vivid, 3 = moderately clear 
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and vivid, 4 = vague and dim, 5 = no image at all, you only ‘know’ that you are thinking of 
the object. In the current study, internal consistency was excellent (α = .89). 
Procedure and Treatment 
 Both treatments comprised 12 weekly, 2-hour sessions plus a one-month follow-up. 
The SIAS and SPS were administered at pre-treatment, post-treatment, and at one-month 
follow-up. The BFNE-S and DASS were administered prior to each treatment session. The 
SUIS and VVIQ were administered at pre-treatment for the imagery-enhanced group only. 
Treatment integrity was encouraged by the use of a detailed treatment manual with therapist 
instructions, patient handouts, and worksheets. All groups were co-facilitated by two 
masters- or doctoral-level clinical psychologists or a clinical psychologist and intern. Groups 
comprised of between 3 and 12 participants (M = 7.0, SD = 2.5). 
The imagery-enhanced protocol was modified from a manual demonstrated to be 
efficacious (Rapee et al., 2009) and effective (McEvoy et al., 2012). The modifications are 
detailed in McEvoy and Saulsman (2014). Many of the imagery-based strategies were 
modified for use in a group setting from those described in Hackmann, Bennet-Levy, and 
Holmes (2011). The protocol was designed to target six main mechanisms: negative social 
images, avoidance, safety behaviours, negative self-images, self-focused attention, and 
negative core beliefs. Session 1 involved socialising patients to the cognitive behavioural 
model of SAD and presenting the rationale for working with negative past, present, and 
future social images rather than negative thoughts. Patients were encouraged to transform 
negative thoughts into images to encourage specificity and because evidence suggests that 
imagery has stronger associations with emotions than verbal-linguistic thoughts. Session 2 
introduced imagery challenging and Session 3 introduced coping imagery and provided a 
rationale for using behavioural experiments to target avoidance. Session 4 involved a within-
session group behavioural experiment (i.e., the group walking down the street in a straight 
line) after which patients began developing individualised behavioural experiment 
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hierarchies. Session 5 involved psychoeducation about the importance of dropping safety 
behaviours followed by a behavioural experiment with and without safety behaviours. 
Session 6 involved video-feedback from a spontaneous speech task, Session 7 involved 
within-session behavioural experiments (i.e., shame-attacking), and Session 8 involved 
attention training and focusing. Session 9 was the imagery rescripting session and Session 
10 involved a series of within-session individual shame-attacking behavioural experiments. 
Session 11 focused on the development of new core beliefs using positive imagery which 
formed the basis for developing future action plans. Session 12 involved a review of 
treatment components, relapse prevention, and a future-oriented imagery exercise. All 
sessions involved a homework review, new content including in-session skills practice, 
summary of three take home messages, and homework for the following week. The one-
month follow-up session involved a review of progress, treatment principles, relapse 
prevention plans, and future goal-setting. 
The historical control protocol targeted the same six mechanisms  using 
predominantly verbal-linguistic methods (except negative social thoughts rather than 
images). Imagery was not mentioned during any of the treatment components with the 
exception of the video-feedback session. All other components were completed within the 
verbal mode (see McEvoy & Saulsman, 2014, and Rapee et al., 2009). Idiosyncratic 
cognitive content (imagery or verbal thoughts) for all strategies across both treatments was 
selected by patients based on their own individual experiences, although the process of 
working on the content was structured within the manualised tasks. 
Data analysis 
All analyses were conducted using the statistical software R version 3.1.1 (R 
Development Core Team, 2014). The imagery-enhanced and historical control groups were 
compared on a range of pre-treatment clinical and demographic variables using Chi-square 
tests with the Wilson confidence interval (Newcombe, 2013, binary variables), or 
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independent samples t-tests and confidence intervals for mean differences using the Welch-
Satterthwaite approach (Cumming, 2012, continuous variables). Treatment acceptability was 
compared in terms of: (i) the mean number of sessions completed, and (ii) the proportion of 
patients who received a high dose of treatment (≥ 9 sessions). Pearson correlations were 
used to explore whether the dropout was associated with clinical or demographic variables. 
Mixed-effects model repeated measures (MMRM) analyses were used to compare 
treatments on the SIAS, SPS, BFNE-S and DASS. MMRM or multiple imputation (MI) 
were used to correct for potential biases caused by missing data (National Research Council 
Panel on Handling Missing Data in Clinical Trials, 2010). These methods estimate how the 
symptoms of patients who dropped out would have changed had they stayed in treatment 
using an intent-to-treat approach. In the current paper, MMRM was used to handle missing 
data for the primary analyses of treatment efficacy and for computing effect sizes. For other 
analyses where it was not feasible to use MMRM, such as baseline comparisons of binary or 
ordinal variables, MI was used. One hundred imputed datasets were generated using the 
random-forest multiple imputation by chained equations algorithm (Shah, Bartlett, 
Carpenter, Nicholas, & Hemingway, 2014). Analyses of the 100 imputed datasets were 
combined using Rubin’s rules (Van Buuren, 2012). MI analyses were conducted using the R 
packages mice (Van Buuren, 2012) and CALIBERrfimpute (Shah, Bartlett, Hemingway, 
Nicholas, & Hingorani, 2014). 
Primary analyses tested whether changes from (i) pre-treatment to post-treatment, 
and (ii) pre-treatment to follow up, were greater for imagery-enhanced than the control 
treatment. Secondary analyses explored trajectories of change across each treatment session 
on the BFNE-S and DASS. MMRM analyses were conducted using R’s nlme (Pinherio & 
Bates, 2000) and lsmeans (Lenth, 2014) packages. All MMRM analyses were intent-to-treat, 
two-tailed, and an unstructured (co)variance matrix was used to model the within-subject 
errors. Within-treatment effect sizes (standardised mean change scores) were calculated for 
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each intervention using the following formula: d = (M pre – M post or fu) / SD. Between-
treatment effect sizes were calculated by first computing the mean change from pre-to-post 
(or follow-up) treatment for each intervention, and then using the formula: d = (Mean 
Change IECBGT – Mean Change CONTROL) / SD. The standardiser for each effect size was the 
pre-treatment standard deviation, pooled across the two treatments (Morris, 2008). 
Reliable change (RC) criteria were identical to those reported in McEvoy et al. 
(2012) and McEvoy and Saulsman (2014), which were based on Jacobson and Truax’s 
(1991) method. The magnitude of change required to achieve RC on the SIAS and SPS were 
8.84 and 10.66, respectively. The cutoff for achieving Clinically Significant Change (CSC) 
was defined as the mid-point between the means of clinical and normative samples from 
Carleton et al. (2014), which corresponded to 40.56 for the SIAS and 31.61 for the SPS. To 
be classified as having achieved CSC an individual must have scored above the CSC cutoff 
before treatment, achieved RC, and scored below the CSC cutoff after treatment. Individuals 
who scored below the CSC cutoff at pre-treatment were excluded from these analyses. 
Pearson correlations were used to examine whether pre-treatment VVIQ and SUIS scores 
were associated with symptom change for the imagery-enhanced treatment. 
For CSC analyses our goal was to determine the proportion of patients in each group 
who definitely achieved CSC. Patients who discontinue treatment, particuarly early in 
treatment, are unlikely to achieve CSC. Using imputed data would therefore overestimate 
the likelihood of patients meeting CSC criteria, and disproportiately so for the control group 
in this study where a substantially larger proportion of patients discontinued earlier in 
treatment. Therefore, CSC analyses were based on all available observed data at post-
treatment and follow up. 
Results 
Baseline Characteristics 
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Pre-treatment demographic and clinical characteristics for the imagery-enhanced and 
historical control groups are compared in Table 1. The majority of differences were small 
and not statistically significant, including age, educational achievement, employment status, 
and clinical features such as the proportion of patients with a comorbid diagnosis. There 
were no pre-treatment differences on the SIAS, SPS, or BFNE-S (see Table 2). There was a 
small but statistically significant difference on the DASS, with imagery-enhanced patients 
being slightly more severe. Overall, the findings suggest that the composition of the 
imagery-enhanced and control samples was similar at pre-treatment. 
Adherence to Treatment 
Adherence to treatment in the imagery-enhanced group was high. The mean number 
of attended sessions was 10.9 (median = 12), and nearly all patients (n = 48, 91%) 
completed a high dose of treatment. One patient discontinued after one session, and another 
after two sessions, due to scheduling clashes with their University timetables. Both patients 
were participating in subsequent groups at the time of manuscript preparation. The three 
other patients who dropped out completed between 5 and 8 sessions. One patient 
discontinued due to a life crisis unrelated to treatment, one due to difficulties with CBT, and 
no reason was recorded for the other patient. 
Adherence to treatment was poorer in the control group. The mean number of 
sessions completed was 9.1 (median = 10) and only 65% received a high dose. Imagery-
enhanced patients completed a mean of 1.8 sessions more than the controls, 95% CI [0.8, 
2.7], p < .001), and substantially more imagery-enhanced patients received a high dose of 
treatment (difference = 24.7%, CI [11.4, 34.7], p = .001). 
 The strongest demographic and clinical predictors (listed in Tables 1 and 2) of 
attendance were variables related to depression. These included having a diagnosis of major 
depression or dysthymia (r = -.24, p = .001), the number of previous suicide attempts (r = -
.24, p = .002), prior psychiatric hospitalization (r = - .21, p = .006), the number of previous 
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self-harm attempts (r = .19, p = .012), number of comorbid diagnoses (r = -.17, p = .023), 
and having a tertiary education (r = .17, p = .024). Other variables were only weakly related, 
or not related at all, to the number of sessions completed (rs < |.16|, all ps > .05). 
There was evidence of an interaction between depression and treatment type, as can 
be seen in Figure 1. A diagnosis of depression was unrelated to adherence amongst imagery-
enhanced patients, with the mean number of sessions attended being practically identical for 
those with (M = 10.7) and without (M = 11.3) depression. In contrast, control patients with 
depression (M = 8.3) completed, on average, two less sessions than those without depression 
(M = 10.3). Depressed patients in the imagery-enhanced group completed 2.4 more sessions 
than those in the control group, 95% CI [1.0, 3.8], p = .001. Nearly all (88%) of the 
depressed imagery-enhanced patients received a high dose of treatment, compared to just 
over half (57%) of controls (difference = 31%, 95% CI [9, 51], p = .004). 
Mean Changes in Symptoms 
Table 2 displays MMRM estimates of pre-treatment, post-treatment, and follow-up 
means for the SIAS, SPS, BFNE-S and DASS. Table 3 contains unstandardised and 
standardised effects sizes, and p values for tests of differences between the treatments. 
Observed means and standard deviations, along with MMRM and MI estimates for every 
session, are provided in the supplementary tables. Patients in both treatments experienced 
very large reductions in social anxiety symptoms. The mean reduction in interaction anxiety 
(SIAS) during treatment was three points larger for the imagery group, which increased to 
six points by follow up. The difference was statistically significant at follow up. There were 
no differences in performance anxiety (SPS). There were large and statistically significant 
differences between the treatments on both the BFNE-S and DASS. Scores decreased more 
for the imagery-enhanced than controls during treatment. 
 On the DASS, significant differences were first detected at session four (2.8 point 
difference, p = .007), and outcomes for patients in imagery-enhanced treatment remained 
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superior to those of controls at all subsequent sessions except session eight (Figure 2). On 
the BFNE-S, a significant difference was first detected at session nine (2.3 point difference, 
p = .029) and outcomes continued to be superior at all subsequent sessions except session 
ten. Differences were nearly significant at sessions three (p = .065) and five (p = .054). 
Standardised Effect Sizes 
 Within- and between-group standardised effect sizes are displayed in Table 3. All 
within-group effects exceeded 0.8, which is large (Cumming, 2012; Sawilowsky, 2009).  
For patients in the imagery-enhanced group, the largest change in symptoms from pre-to-
post treatment was on the SIAS (d = 1.93), followed by the BFNE-S (d = 1.41), DASS (d = 
1.38), and SPS (d = 1.21). By follow-up, the effect size exceeded two standard deviations on 
the SIAS and approached two standard deviations on the BFNE-S. According to 
Sawilowsky’s (2009) an effect of 1.2 is very large and an effect size of 2.0 is huge. The 
between group effect sizes indicated an advantage for IE-CBGT over the control except on 
the SPS, on which there were no differences (Table 2). The size of the difference during 
treatment (i.e,. pre to post) was moderate on the BFNE-S and DASS. The pre-to-post effect 
was somewhat smaller on the SIAS, but the size of the difference had doubled by follow up.  
Clinical Significance 
 Four imagery-enhanced patients were excluded from RC and CSC analyses on the 
SIAS because they were missing scores at pre-treatment. None of the imagery-enhanced 
patients scored below the CSC cutoff for the SIAS at pre-treatment. Of the patients included 
in the analysis (n = 49), 73% (n = 36) had reliably improved and 37% (n = 18) achieved 
CSC by post-treatment, and 78% (n = 38) had reliably improved and 41% (n = 20) achieved 
CSC at follow-up. Twelve control patients were excluded due to missing pre-treatment SIAS 
data (n = 4) or pre-treatment scores below the CSC cut off (n = 8). Of the patients included 
in the analysis (n = 117), 48% (n = 56) reliably improved and 29% achieved CSC by post-
treatment, and 50% (n = 58) reliably improved and 27% (n = 32) achieved CSC by follow-
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up.  Substantially more imagery-enhanced patients achieved reliable change than control 
patients, both at post-treatment (Diff = 26%, 95% CI [9, 39], p = .002) and at follow up (Diff 
= 28%, 95% CI [12, 41], p = .001).  In terms of CSC, imagery-enhanced treatment was 
numerically but not statistically superior to the control at both post-treatment (Diff = 8%, 
95% CI [-7, 24], p = .331) and follow up (Diff = 13%, 95% CI [-2, 29], p = .088). 
 Eleven imagery-enhanced patients were excluded from RC and CSC analyses on the 
SPS because they were missing scores at pre-treatment (n = 3) or had pre-treatment scores 
below the CSC cutoff (n = 8). Of the patients in the analysis (n = 42), 71% (n = 30) achieved 
reliable change and 50% (n = 21) achieved CSC at post-treatment, and 83% (n = 35) 
achieved reliable change and 69% (n = 29) achieved CSC at follow-up. Forty-five control 
patients were excluded due to missing pre-treatment SPS data (n = 16) or pre-treatment 
scores below the CSC cutoff (n = 29). Of the patients included in the analysis (n = 84), 52% 
(n = 44) achieved reliable change and 48% (n = 40) achieved CSC at post-treatment, and 
57% (n = 48) achieved reliable change and 45% (n = 38) achieved CSC at follow-up. 
Substantially more imagery-enhanced patients achieved reliable change at post-treatment 
(Diff = 19%, 95% CI [1, 35], p = .041), and at follow up (Diff = 26%, 95% CI [9, 40], p = 
.003). There was no difference in rates of CSC at post-treatment (Diff = 3%, 95% CI [-16, 
20], p = .801), but by follow up considerably more imagery-enhanced patients had achieved 
CSC (Diff = 24%, 95% CI [5, 39], p = .012). 
Imagery Use and Imagery Ability as Predictors of Change 
The mean scores on the VVIQ and SUIS were 10.6 (SD = 4.1) and 35.1 (SD = 8.3), 
and the correlation between them was r = -.13 (p = .36).  The VVIQ (all rs <.27, ps > .05) 
and the SUIS (all rs < .17, ps>.28) were not significantly associated with pre-treatment 
scores on the SIAS, SPS, BFNE-S or DASS. There were modest correlations between the 
VVIQ and symptom change during treatment. The VVIQ was most strongly associated with 
change in BFNE-S scores (r = .32, p = .03), followed by the SIAS (r = .29, p = .04), SPS (r 
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= .26, p =.06) and DASS (r = .21, p =.16). The DASS correlation was attenuated by a single 
outlier; once it was removed, the correlation was .34 (p = .02). SUIS scores were not 
predictive of symptom change on the SIAS, SPS, BFNE-S or DASS (rs = .01, .00, -.02 and -
.22, respectively, all ps > .16). 
 Because imagery ability was associated with symptom change, we explored whether 
outcomes for imagery-enhanced patients with low imagery ability were worse than those of 
control group patients. Low imagery ability was defined as a VVIQ score at the 25th 
percentile (i.e., 8). For each symptom measure, we used regression to estimate the mean 
change during treatment for imagery-enhanced patients with low imagery ability. These 
estimated changes were then compared to the mean changes for control patients. Imagery-
enhanced patients with low imagery ability had similar or higher mean change scores 
compared to controls on the SIAS (17.00 vs. 16.30), BFNE-S (7.68 vs. 6.28), and DASS 
(10.00 vs. 7.10), but somewhat lower on the SPS (16.70 vs. 19.10). 
Discussion 
Social anxiety disorder (SAD) is an early onset and debilitating disorder that tends to 
be unremitting without treatment (DeWit, Ogborne, Offord, & McDonald, 1999). CBT is 
efficacious and effective for SAD but a substantial minority of sufferers do not respond to 
treatment in community clinics (McEvoy, 2007; McEvoy et al., 2012). In an attempt to 
improve outcomes, the first aim of this study was to compare the acceptability and 
effectiveness of an imagery-enhanced CBGT protocol to a large sample of historical 
controls who completed predominantly verbally-based CBGT. Importantly, both 
interventions were delivered in the same community mental health clinic and were the same 
length, patients were recruited via the same referral pathways, and the groups did not 
significantly differ on a range of clinical and demographic variables, suggesting that both 
samples were drawn from a similar population. 
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The imagery-enhanced protocol was associated with very high retention and 26% 
more patients received a high dose of the imagery-enhanced protocol compared to historical 
controls. The imagery-enhanced completion rate of 91% compared very favourably to 
previous effectiveness trials in community clinics (Hofmann & Suvak, 2006; Lincoln et al., 
2005). Furthermore, while comorbid depression was associated with poorer attendance in 
the verbally-based intervention this was not the case for the imagery-enhanced intervention. 
The imagery-enhanced protocol therefore appeared to be highly acceptable within this 
severe and highly comorbid sample. 
Both treatments were highly effective and demonstrated large effect sizes on all 
outcome measures. As hypothesised, between-groups effect sizes demonstrated that the 
imagery-enhanced group improved more on the BFNE-S and DASS at post-treatment (small 
to medium effect sizes), and on the SIAS, BNE and DASS at follow-up (medium to large 
effect sizes). The magnitude of these differences was striking given that both treatments 
targeted the same key mechanisms, albeit via predominantly different modes (verbal vs. 
imagery). Within-groups effect sizes were largest for the imagery-enhanced group and 
compared very favourably to previous group and individual cognitive behavioural therapy 
trials (Clark et al., 2003; McEvoy et al., 2012; Rapee et al., 2009). Weekly comparisons 
between the imagery and control groups demonstrated that scores on the BFNE-S and DASS 
significantly diverged in favour of the imagery-enhanced group. A majority of patients 
receiving the imagery intervention achieved reliable change, and around one-third and two-
thirds achieved clinically significant change on social interaction anxiety and performance 
anxiety, respectively. A higher proportion of the imagery-enhanced group achieved reliable 
change on social interaction anxiety and performance anxiety at post-treatment and follow-
up, and a significantly higher proportion of the imagery-enhanced group achieved CSC on 
the SPS at follow-up. Overall, the imagery-enhanced protocol appeared to be more 
acceptable and effective than the predominantly verbal-linguistic control intervention. 
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The one exception to this pattern was that both groups improved to a similar degree 
on performance anxiety, for which there are at least two potential explanations. First, all 
patients scored within the clinical range on the social interaction anxiety scale but not on 
performance anxiety, which is suggestive of a predominance of generalised social 
interaction anxiety. The exclusion of the DSM-IV (APA, 1994) generalised specifier, but 
retention of the performance-only specifier, in DSM-5 (APA, 2013) reflects the fact that 
most patients in clinical practice experience anxiety in a broad array of social situations. 
Performance situations may have been only one of numerous social anxiety triggers and the 
SIAS therefore may have been a more comprehensive and sensitive measure of the sample’s 
broad spectrum of social fears. The substantially larger pre-treatment standard deviation on 
the SPS compared to the SIAS is consistent with performance anxiety being prominent for a 
smaller proportion of the sample compared to interaction anxiety. Second, both programs 
included an identical number of formal within-session performance exposure tasks (i.e., one 
video-taped presentation) and a larger number of social interaction tasks. Given the 
generalised nature of the patients’ social fears they may have also prioritised social 
interactions for homework tasks. Thus, during treatment there was likely to have been a 
larger ‘dose’ of imagery enhancements within social interaction situations relative to 
performance situations. Individualised hierarchies were not retained for analysis, so this 
explanation is speculative. Future studies directly comparing imagery- to verbally-based 
interventions for performance anxiety in particular are required to more clearly determine 
whether one mode is superior to the other for this subtype. 
The second aim of this study was to examine whether (a) self-reported tendencies to 
operate within an imagery mode and (b) imagery ability were associated with outcomes in 
the imagery-enhanced group. Patients’ self-reported tendency to use imagery in daily life 
was not associated with symptom change, suggesting that those who naturally operate within 
an imagery mode do not necessarily do better in the imagery-enhanced intervention than 
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those who do not have this tendency. This finding is consistent with previous studies that 
have failed to find this association (e.g., Lee & Kwon, 2013). It is important to note that 
patients were not discouraged from applying their skills to negative verbal-linguistic 
thoughts throughout the imagery-enhanced protocol, but they were encouraged to transform 
thoughts into specific vivid images, for example, before and after cognitive restructuring and 
behavioural experiments. Few patients reported an inability to transform their thoughts into 
images, although some reported somewhat fragmented images or a ‘felt sense’ rather than 
vivid images. Greater imagery awareness emerged for some patients during the group. For 
instance, one patient reported that she always thinks in verbal thoughts and then 
immediately described it as being “like a whirlwind of thoughts above her head.” This vivid 
metaphorical image could then be transformed in therapy and, in turn, the meaning of the 
image as an uncontrollable and chaotic spiral could be modified. 
The association between self-reported imagery ability and symptom improvement 
was modest but significant, suggesting that those who reported being able to elicit more 
vivid (benign) images before treatment achieved greater symptom relief during treatment. It 
is plausible that the imagery-enhanced protocol was more effective for those with greater 
imagery ability, but this study cannot definitively support this proposition given that this 
measure was only administered to the imagery-enhanced group. It is important for future 
research to demonstrate that poor imagery ability is not a proxy for cognitive inflexibility 
more generally, a core feature of emotional disorder (e.g., Hayes, Strosahl, & Wilson, 2011), 
which could also predict outcomes from verbally-based interventions. However, if imagery 
ability was simply a proxy for cognitive flexibility it would be expected to negatively 
correlate with symptom severity at pre-treatment, but this was not the case. It is also 
important to note that those with poorer imagery ability achieved comparable change scores 
to the historical controls, suggesting that they did not do more poorly in the imagery-
enhanced protocol but rather that those with superior imagery ability did better. 
Imagery-Enhanced CBGT for Social Anxiety Disorder 22 
Additionally, 69% of the sample scored below the mid-point on the VVIQ, suggesting that 
relatively poor imagery ability overall did not adversely affect outcomes. Therefore, 
regardless of imagery ability the imagery-enhanced protocol may still prove to be the 
treatment of choice. 
A large body of evidence suggests that similar emotional, cognitive, and 
physiological responses are observed in both imagined and actual events (Kosslyn, Ganis, & 
Thompson, 2001), and recent evidence has demonstrated that imagery has a particularly 
powerful relationship to emotions compared to verbal-linguistic activity (Holmes & 
Mathews, 2010). These literatures suggest that imagery-based therapeutic techniques may 
facilitate greater emotional activation and modification than verbal-linguistic techniques 
alone. Imagery in psychotherapy is not new (Beck, Rush, Shaw, & Emery, 1979; Edwards, 
2007) and it has been incorporated into treatments for a large range of disorders. However, 
the contribution of imagery-based techniques to clinical outcomes has recently garnered 
considerable interest within the emotional disorder literature in general and the SAD 
literature in particular. Studies investigating the impact of imagery rescripting alone (e.g., 
Nilsson et al., 2012) and within CBT packages (Clark et al., 2006) delivered individually 
have been promising. 
This study builds on these earlier studies in several ways. First, other than the pilot 
study (McEvoy & Saulsman, 2014) we are unaware of any previous study incorporating past 
imagery rescripting within a group context. Second, imagery was incorporated into all 
treatment components in an attempt to more comprehensively exploit the strong imagery-
emotion association. Third, our study found that the imagery-enhanced protocol was 
associated with low attrition, including amongst those with comorbid depression. Emerging 
evidence suggests that dysphoria and anxiety are associated with a deficit of positive 
imagery (Holmes, Lang, Moulds, & Steele, 2008; Morina, Deeprose, Pusowski, Schmid, & 
Holmes, 2011). Although our finding requires replication, it is tempting to speculate that the 
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imagery-enhanced intervention better engaged patients with and without comorbid 
depression by explicitly and repeatedly prompting more realistic and positive imagery to 
correct this deficit. Fourth, the finding that greater imagery ability was associated with 
greater symptom change during the imagery-enhanced protocol was also novel and may 
suggest that, to the degree that imagery ability is trainable, techniques designed to enhance 
imagery ability prior to an imagery-enhanced intervention could increase treatment potency. 
This intriguing possibility requires further research. 
This study’s findings must be considered in light of several limitations. Patients were 
not randomised to treatments, which may have introduced systematic differences across the 
samples. This concern was somewhat mitigated by the similarities in the samples in terms of 
clinical and sociodemographic variables, treatment setting, recruitment procedures and 
clinicians. It is noteworthy that MMRM estimates outcomes assuming all patients had 
completed treatment. Attrition was low for the imagery group, so we can be confident that 
the MMRM estimates for this group closely approximated those likely to be seen in clinical 
practice. In contrast, the higher attrition rate in the control group was likely to have 
overestimated treatment effectiveness in practice, because those who discontinued treatment 
were unlikely to have achieved the same degree of benefit than if they had attended the 
whole program (as is assumed from MMRM). The estimated between-treatment effect sizes 
are therefore more likely to be underestimates than overestimates. 
The lack of a waitlist or placebo control group also means that we cannot definitively 
conclude that patients would not have improved without intervention or that the specific 
content of the treatments caused the symptom changes. However, these possibilities are 
unlikely given that (a) pre-treatment means were amongst the most severe in the published 
literature, (b) SAD is chronic and unremitting without treatment (DeWit et al., 1999), (c) the 
effect sizes were amongst the largest in the published literature, including trials that have 
included control groups (Clark et al., 2003, 2006), and (d) the historical control treatment 
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used in this study has been demonstrated to be more efficacious than more traditional CBT 
and stress management control groups (Rapee et al., 2009) and equally effective across 
research and community mental health settings (McEvoy et al., 2012). 
Another limitation was that treatment adherence was not independently assessed, but 
was instead supported by the use of detailed therapist notes, handouts, and worksheets. 
Effectiveness trials emphasise external validity and the important contribution they make to 
transporting efficacious treatments into real world clinics has been well recognised (Stewart 
& Chambless, 2009). It is critical for the dissemination of evidence-supported treatments 
that efficacious treatments are shown to be effective in clinically representative samples and 
settings. Nonetheless, the superiority of imagery-enhanced group treatment found in this 
study needs to be verified in a randomised controlled trial. Our reliance on self-report 
measures was also a limitation. Finally, the standard procedure within the community clinic 
is to provide a one-month follow-up, but longer-term assessment of trajectories of change 
would be informative. 
This study found that an imagery-enhanced CBGT program in a community clinic 
was associated with high retention and large effect sizes, and compared well to historical 
controls who completed a predominantly verbally-based intervention. The ability to evoke 
vivid imagery was associated with superior outcomes from imagery-enhanced CBGT but 
there was no evidence that those without this ability did more poorly than those completing 
the comparison treatment. Future randomised controlled trials investigating whether 
imagery-based techniques can enhance outcomes for SAD and other emotional disorders 
would be informative, as would studies investigating differential mechanisms of change 
across verbally- and imagery-based interventions.
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Table 1 
Comparison of pre-treatment demographic and clinical characteristics for the 
imagery enhanced and historical control groups 
  IE-CBGT   CONTROL   Difference     
Measure (n = 53)   (n = 129)   Est   95% CI   p 
Demographics 













































           Diagnoses 




































           Other clinical features 






[-18,   8] 
 
.45 















[-19,   8] 
 
.42 
Medicated 60   65   -5   [-21, 11]   .53 
Note.  The numbers are percentages except for age, which is a mean and standard 
deviation. IE-CBGT = imagery enhanced cognitive behavioural group therapy, Est = 
estimate, MDD = major depressive disorder, GAD = generalised anxiety disorder. 
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Table 2 
MMRM estimated means (and standard errors) at pre-treatment, post-treatment, and 
follow up 
Measure and time 
IE-CBGT   CONTROL 
M SE   M SE 
SIAS 
     Pre 58.7 1.4 
 
57.6 0.9 
Post 39.4 2.0 
 
41.3 1.5 
Follow Up 36.9 2.2 
 
41.9 1.7 
      SIAS 
     Pre 42.8 2.3 
 
43.0 1.5 
Post 23.7 2.0 
 
23.9 1.5 
Follow Up 21.8 2.0 
 
22.9 1.6 
      BFNE-S 
     Pre 32.2 0.8 
 
31.8 0.6 
Post 23.3 1.1 
 
25.5 0.8 
Follow Up 21.5 1.1 
 
24.6 0.8 
      DASS 
     Pre 20.8 1.1 
 
18.0 0.7 
Post 9.9 1.1 
 
11.0 0.8 
Follow Up 9.4 1.3   10.4 0.9 
 
Note.  IE-CBGT = imagery enhanced cognitive behavioural group therapy, SIAS = 
Social Interaction Anxiety Scale, SPS = Social Phobia Scale, BFNE-S = Brief Fear of 
Negative Evaluation scale, DASS = Depression, Anxiety, and Stress Scales. 
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Table 3 
 
MMRM estimates of unstandardised and standardised within-group and between-group treatment effects 
 
  Mean Changes   Standardized Effect Sizes     
Measure and Time IE-CBGT Control   Diff 95% CI   IE-CBGT Control Diff   p 
SIAS 
            Pre to post 19.3 16.3 
 
3.0 [-1.8, 7.9] 
 
1.93 1.63 .30 
 
.224 
Post to follow up 21.8 15.7 
 
6.1 [ 0.8, 11.3] 
 
2.18 1.57 .61 
 
.024 
             SPS 
            Pre to post 19.0 19.1 
 
0.0 [-5.3, 5.3] 
 
1.20 1.21 .00 
 
.991 
Post to follow up 21.0 20.0 
 
1.0 [-4.6, 6.5] 
 
1.33 1.27 .06 
 
.737 
             BFNE-S 
            Pre to post 8.8 6.3 
 
2.5 [ 0.2,  4.9] 
 
1.41 1.01 .41 
 
.033 
Post to follow up 10.6 7.3 
 
3.4 [ 0.9, 5.9] 
 
1.70 1.16 .54 
 
.008 
             DASS 
            Pre to post 10.8 7.1 
 
3.8 [ 1.2, 6.3] 
 
1.39 0.90 .48 
 
.004 
Post to follow up 11.4 7.6   3.8 [ 0.8, 6.8]   1.45 0.97 .48   .014 
 
 
Note. IE-CBGT = Imagery enhanced cognitive behavioural group therapy; Diff = Difference between the IE-CBGT and Control groups; CI = 
Confidence Interval. SIAS = Social Interaction Anxiety Scale, SPS = Social Phobia Scale, BFNE-S = Brief Fear of Negative Evaluation scale, 
DASS = Depression, Anxiety, and Stress Scales. p value is for the difference between the mean change scores. Pooled pre-treatment standard 
deviations used to compute the standardised mean changes were 9.98 (SIAS), 15.80 (SPS), 6.25 (BFNE-S), and 7.83 (DASS). 
 




Figure 1.  Boxplot showing the number of treatment sessions completed, stratified by 
treatment type and depressive diagnosis. Most IE-CBGT patients completed a high 
number of sessions irrespective of whether they were depressed or not.  Amongst 
control patients, session attendance was much more variable. This was particularly the 
case for depressed patients, as is evident from the massive spread of the box and 
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Figure 2.  Trajectories of symptom improvement on the Brief Fear of Negative 
Evaluation Scale (BFNE-S) and Depression, Anxiety and Stress Scale (DASS) across 
treatments sessions, and at one month follow up. Mean improvements in symptoms 








Figure 3.  Dotplot of between-group pre-to-post treatment, and pre-treatment to 
follow up standardised effect sizes. A positive effect size indicates that symptoms 
reduced more for IE-CBGT patients than controls. Vertical lines correspond to what 
are often considered to be nil (0.0), small (0.2), medium (0.5) and large (0.8) effects. 
 
